For next month I will go over the CTAD data in detail. Please, subscribed. I will post at least 3 post a week.
Do not trade this blog as 4 billion years of evolution is against me and possibly even God laughs at it, He has a great sense of humor! And I am long $AVXL FYI
Subscribe to get access
Read more of this content when you subscribe today.
I downloaded copy of the paper listed on the slide 8 and that is what I learned.
Subscribe to get access
Read more of this content when you subscribe today.
Subscribe to get access
Read more of this content when you subscribe today.
Subscribe to get access
Read more of this content when you subscribe today.
Blarcamesine has the making of a drug which can become the first choise for patients with Parkinson’s, either slowing progress of the disease or even reversing it for some. The prospects here are even beter than they are with Alzheimer’s
I am sorry for multiple log-in buttons, I am learning how to use the editor, but the same login should be used for all paragraphs. I apologize.